Medtrack One View - A New More Powerful Biopharmaceutical Intelligence Tool Is Now Available

NEW YORK, March 1, 2012 /PRNewswire/ -- Medtrack, a Citeline product, has released the much anticipated Medtrack One View. One View is a complete redesign of Medtrack that has made our platform stronger than ever before.  These enhancements will give clients the ability to better find pipeline information, discover deal and partnership opportunities; identify companies with a track record of success in developing and commercializing drugs; patent information and much more.

With new search capabilities, new ways of viewing data and new options to customize the site, clients can design Medtrack to support all of their unique information needs. Medtrack One View will deliver to clients, in-depth analysis in a user-friendly interface.   

According to Joe Walsh, Chief Commercialization Officer, Citeline, "One View goes further than any competitor in leveraging the deep interrelations across data to support analysis and accelerate the business decision making process."

From startups to market leaders, and across dozens of functions, thousands of individuals rely on Medtrack data every day to identify opportunities, analyze the market, and support critical decisions.

About Medtrack

Medtrack is the leader in biopharmaceutical intelligence. Medtrack's integrated platform offers clients a robust insight into pharmaceutical pipeline, sales, epidemiology, patents and more to give a comprehensive view of the biopharmaceutical business landscape. To find out more about Medtrack go to www.medtrack.com or call (570) 687-9318 in the U.S, or +44 (0) 20 7551 9622 internationally.

For further information, call:
Carolle St. Fleur
Tel: 978-664-4498
Email: [email protected]

SOURCE Medtrack